Compare AEIS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | CYTK |
|---|---|---|
| Founded | 1981 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.0B |
| IPO Year | 1995 | 2004 |
| Metric | AEIS | CYTK |
|---|---|---|
| Price | $257.41 | $63.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | ★ $223.20 | $82.38 |
| AVG Volume (30 Days) | 368.5K | ★ 2.2M |
| Earning Date | 02-11-2026 | 02-26-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 236.95 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | ★ $1,724,842,000.00 | $87,211,000.00 |
| Revenue This Year | $22.67 | $339.72 |
| Revenue Next Year | $12.82 | $79.08 |
| P/E Ratio | $62.37 | ★ N/A |
| Revenue Growth | 17.19 | ★ 2609.26 |
| 52 Week Low | $75.01 | $29.31 |
| 52 Week High | $238.92 | $70.98 |
| Indicator | AEIS | CYTK |
|---|---|---|
| Relative Strength Index (RSI) | 71.66 | 50.55 |
| Support Level | $201.56 | $60.30 |
| Resistance Level | $232.00 | $65.08 |
| Average True Range (ATR) | 9.00 | 2.78 |
| MACD | 2.87 | 0.10 |
| Stochastic Oscillator | 95.29 | 60.66 |
Advanced Energy Industries Inc provides precision power-conversion measurement and control solutions that transform power into various forms for use in manufacturing and industrial equipment and applications. The firm serves original equipment manufacturers and end customers in the semiconductor, flat panel display, solar panel, and other industrial capital equipment markets. Products include thin-film power-conversion systems, which control and modify raw electrical power into a customizable, predictable power source, and power control modules, which control and measure temperature during manufacturing cycles. A majority of the firm's revenue is generated in United States, with the rest from Mexico, Taiwan, China and All others.
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.